Is it time for China to prioritize pan-genotypic regimens for treating patients with hepatitis C?
Introduction The treatment of hepatitis C has entered the pan-genotypic era, but the
effectiveness is not good for the genotype 3b patients who have a large proportion in China …
effectiveness is not good for the genotype 3b patients who have a large proportion in China …
[HTML][HTML] Universal screening and treatment towards the elimination of chronic hepatitis C in China: an economic evaluation
K Fang, H Wang, Y Lin, L Zheng, S Li, J Wu - Public Health, 2024 - Elsevier
Objectives China has the largest number of hepatitis C virus (HCV) infection in the world, but
current levels of diagnosis and treatment are low. The objective of this study was to assess …
current levels of diagnosis and treatment are low. The objective of this study was to assess …
[PDF][PDF] HCV RNA Positivity among Hepatitis C Patients in Chongqing, China from 2004 to 2021: A Cross-Sectional Study
Y HE, S YE, W ZHANG, R LU, J LIN, C ZHOU, G WU - 2024 - assets-eu.researchsquare.com
Background: A substantial number of Hepatitis C virus (HCV) infections have been identi ed,
yet not all diagnosed patients have received treatment, leading to uncertainties in the …
yet not all diagnosed patients have received treatment, leading to uncertainties in the …
HCV RNA Positivity among Hepatitis C Patients in Chongqing, China from 2004 to 2021: A Cross-Sectional Study
HE Yaping, YE Shaodong, W ZHANG, LU Rongrong… - 2024 - researchsquare.com
Background: A substantial number of Hepatitis C virus (HCV) infections have been
identified, yet not all diagnosed patients have received treatment, leading to uncertainties in …
identified, yet not all diagnosed patients have received treatment, leading to uncertainties in …